EML4-ALK rearrangement in patients with NSCLC is a relatively rare event, present in approximately 2–8% of NSCLCs [127,133,134], and most commonly seen in younger patients with AC histology and never- or light-smoking history. Here, ALK is linked to non-small cell lung carcinoma.